These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36240332)

  • 21. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
    Shore ND; Drake CG; Lin DW; Ryan CJ; Stratton KL; Dunshee C; Karsh LI; Kaul S; Kernen K; Pieczonka C; Sieber P; Stewart C; Williams M; Concepcion RS
    Prostate; 2020 Oct; 80(14):1159-1176. PubMed ID: 32779781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study.
    Oswald LB; Schumacher FA; Gonzalez BD; Moses KA; Penson DF; Morgans AK
    Patient Prefer Adherence; 2020; 14():1949-1959. PubMed ID: 33116438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
    Mark JR; McDougall C; Giri VN
    Urol Clin North Am; 2021 Aug; 48(3):311-322. PubMed ID: 34210487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Chiu PKF; Lee EKC; Chan MTY; Chan WHC; Cheung MH; Lam MHC; Ma ESK; Poon DMC
    Front Oncol; 2022; 12():962958. PubMed ID: 35924163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International guidelines for groin hernia management.
    HerniaSurge Group
    Hernia; 2018 Feb; 22(1):1-165. PubMed ID: 29330835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer.
    Wei Y; Wu J; Gu W; Wang J; Lin G; Qin X; Dai B; Gan H; Ye D; Zhu Y
    Oncologist; 2020 Jul; 25(7):e1042-e1050. PubMed ID: 32190957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surgery in oligometastatic prostate cancer.
    Jenjitranant P; Touijer KA
    Prostate Int; 2019 Dec; 7(4):125-130. PubMed ID: 31970136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
    Dai L; Song ZX; Wei DP; Zhang JD; Liang JQ; Wang BB; Ma WT; Li LY; Dang YL; Zhao L; Zhang LM; Zhao YM
    Adv Ther; 2021 Jun; 38(6):2973-2989. PubMed ID: 33881746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
    Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
    Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.
    Golan R; Bernstein AN; Gu X; Dinerman BF; Sedrakyan A; Hu JC
    Cancer; 2018 May; 124(10):2212-2219. PubMed ID: 29579318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics in prostate cancer: implications for clinical practice.
    Szymaniak B; Ross AE; Morgans AK
    Curr Opin Support Palliat Care; 2021 Dec; 15(4):241-246. PubMed ID: 34762074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives of health care use and access to care for individuals living with inflammatory bowel disease in rural Canada.
    Rohatinsky N; Boyd I; Dickson A; Fowler S; Peña-Sánchez JN; Quintin CL; Risling T; Russell B; Wicks K; Wicks M
    Rural Remote Health; 2021 Apr; 21(2):6358. PubMed ID: 33820422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
    Bayne CE; Williams SB; Cooperberg MR; Gleave ME; Graefen M; Montorsi F; Novara G; Smaldone MC; Sooriakumaran P; Wiklund PN; Chapin BF
    Eur Urol; 2016 May; 69(5):775-87. PubMed ID: 26003223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer.
    Haupt F; Berding G; Namazian A; Wilke F; Böker A; Merseburger A; Geworski L; Kuczyk MA; Bengel FM; Peters I
    Adv Ther; 2017 Apr; 34(4):986-994. PubMed ID: 28265811
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.